PMID: 9176073Apr 1, 1997Paper

Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease

Gut
J BauditzS Schreiber

Abstract

In Crohn's disease, inflammation is presumably sustained by an increased production of proinflammatory cytokines, in particular tumour necrosis factor alpha (TNF alpha) and interleukin 1 beta (IL 1 beta). TNF alpha can induce a host of cellular effector events resulting in perpetuation of the inflammatory process. In vivo studies with anti-TNF alpha antibody treatment have led to impressive clinical results. To investigate whether treatment with the TNF alpha inhibitor oxpentifylline results in clinical improvement in corticosteroid dependent chronic active Crohn's disease. Sixteen Crohn's disease patients received oxpentifylline 400 mg four times a day in a four week open label study. Blockade of TNF alpha production in 16 patients with corticosteroid dependent Crohn's disease did not improve the clinical disease activity (CDAI mean (SEM) 188.75 (5.65) versus 185.13 (10.87) or the endoscopic degree of inflammation (CDEIS 14.9 (2.87) versus 14.8 (2.27) or laboratory parameters. In this study, use of the TNF alpha inhibitor oxpentifylline does not improve inflammation in Crohn's disease. This finding suggests that there may be more key mediators than only TNF alpha in the inflammatory process in Crohn's disease.

Citations

Nov 18, 2000·Lancet·S NikolausS Schreiber
Jan 25, 2002·The Bulletin of Tokyo Dental College·T HisamatsuJ Nishida
Mar 7, 2006·Nature Reviews. Drug Discovery·Joshua R Korzenik, Daniel K Podolsky
May 19, 2005·Clinical Chemistry and Laboratory Medicine : CCLM·Lone G M JørgensenIvan Brandslund
Oct 13, 2006·Current Opinion in Gastroenterology·R B Heuschkel
Oct 13, 2006·Current Opinion in Gastroenterology·S Schreiber, J Hampe
Mar 19, 2009·European Journal of Gastroenterology & Hepatology·Pedro Pimentel-NunesFernando Magro
Dec 1, 1999·Inflammatory Bowel Diseases·T HellerP E Darwin
Jan 16, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Ian D R ArnottJack Satsangi
May 20, 2004·Current Treatment Options in Gastroenterology·Karl H. Kim, Gary R. Lichtenstein
May 3, 2000·Alimentary Pharmacology & Therapeutics·S J Bell, M A Kamm
Nov 8, 2002·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Ajeya Shetty, Alastair Forbes
Jun 18, 1999·Gastroenterology Clinics of North America·B E Sands
Nov 4, 2000·Expert Opinion on Investigational Drugs·G Van Assche, P Rutgeerts
Oct 22, 2002·Expert Opinion on Biological Therapy·Herbert Tilg, Arthur Kaser
Dec 1, 2001·Expert Opinion on Biological Therapy·M H HoltmannM F Neurath
Apr 23, 2004·Expert Opinion on Investigational Drugs·Radhika Srinivasan, Gary R Lichtenstein
Jun 5, 2003·Expert Opinion on Biological Therapy·Anthony D BoothDavid R W Jayne
Dec 29, 2000·Annals of Medicine·G Monteleone, T T MacDonald
Dec 8, 2009·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Simone KrebsBilal Omer
Jun 15, 2007·Journal of Clinical Pharmacology·Bruce E Sands, Gilaad G Kaplan
Aug 15, 1998·Baillière's Clinical Gastroenterology·G JärnerotC Tysk
Jul 28, 2004·Trends in Pharmacological Sciences·Katharine H Banner, Michael A Trevethick
May 26, 2004·Best Practice & Research. Clinical Gastroenterology·Silvia MascherettiStefan Schreiber
Nov 29, 2005·La Revue de médecine interne·M KoenigH Rousset
Jun 5, 2004·Gastroenterology Clinics of North America·Joshua R Korzenik
Aug 17, 2014·Gastroenterology·Barrett G LevesqueJean-Frederic Colombel
May 10, 2008·Orvosi hetilap·Péter László Lakatos, László Lakatos
Jul 27, 2001·The American Journal of Gastroenterology·M E BlamG R Lichtenstein
Sep 28, 2000·The American Journal of Gastroenterology·A E BharuchaK D Lindor
Feb 20, 2004·The Cochrane Database of Systematic Reviews·A K Akobeng, M Zachos
Jul 27, 2001·Current Treatment Options in Gastroenterology·Thomas A. Judge, Gary R. Lichtenstein
Jun 6, 2003·Journal of the American Academy of Dermatology·David James Najarian, Alice B Gottlieb

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here